Sanofi(US:SNY) Yahoo Finance·2026-02-10 13:00Group 1: AI's Role in Business Transformation - AI is recognized as a durable engine of transformation that is fundamentally reshaping how companies operate and innovate [1] - The critical factor for companies in 2026 and beyond will be the enterprise-scale implementation of AI, moving from experimentation to operationalization [3] - As organizations implement AI at their core, evidence of long-term value will emerge, particularly in areas like drug discovery and optimized supply chains [3] Group 2: AI in Drug Development - Generative AI has the potential to accelerate early-stage drug breakthroughs, reducing timelines by 25% or more [4] - Sanofi has discovered 10 new drug targets in one year by integrating machine learning and data with lab research, demonstrating AI's active role in decision-making [5] - AI-powered tools have improved clinical trial enrollment rates by 65%, automating patient eligibility and enhancing the efficiency of recruitment processes [6]